Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: The Insight Partners | PRODUCT CODE: 1226840

Cover Image

PUBLISHER: The Insight Partners | PRODUCT CODE: 1226840

North America Malaria Treatment Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Treatment Type ; Route of Administration ; End User

PUBLISHED:
PAGES: 152 Pages
DELIVERY TIME: 1-5 business days
SELECT AN OPTION
PDF (Single User License)
USD 3000
PDF (Site License)
USD 4000
PDF (Enterprise License)
USD 5000

Add to Cart

The North America malaria treatment market is expected to grow from US$ 765.63 million in 2022 to US$ 996.80 million by 2028. It is estimated to register a CAGR of 4.5% from 2022 to 2028.

Rapid Diagnostic Tests for Malaria is Bolstering the North America Malaria Treatment Market

RDTs for malaria can improve the quality of management of the disease. RDTs are proven to be highly affordable and effective for public health programs implemented in low-resource settings. RDTs are widely used in remote areas with limited access to microscopy services. As a result, there has been a rapid rise in the demand for RDTs for malaria. Several RDTs have been developed to test the presence of malaria parasites in blood samples. Identifying and successfully treating malaria in low-transmission areas is critical to reduce transmission and eliminate the disease. Many companies are engaged in developing a wide range of RDTs with high sensitivities. A few of these developments have taken place in recent years. For instance, in November 2020, researchers from Rice University developed a simple microneedle patch like a bandage to detect malaria. With this development, the researchers have stepped on the path of reducing the disease burden in countries struggling with poor health infrastructure. The microneedles loaded on the patch collect interstitial fluid, which contains several biomarkers that help detect malaria. So, the growing number of rapid diagnostic tests for malaria is driving the North America malaria treatment market .

North America Malaria Treatment Market Overview

The North America malaria treatment market is segmented into the US, Canada, and Mexico. The US is dominating the malaria treatment market in the region. According to the Centers for disease control and prevention (CDC), approximately 2,000 cases are reported annually in the United States, mostly in returning travelers and immigrants. Pregnant women and children under five years of age are at the highest risk of contracting malaria and developing severe diseases. Anopheles mosquitoes capable of transmitting malaria ("vectors") endure in the US. Thus, there is a perpetual risk that malaria transmission can resume in the US. In April 2022, the Global Fund reported that malaria cases and deaths had risen primarily due to stalled funding and disruptions from the COVID-19 pandemic. However, efforts to mitigate these impacts are in progress, with the Global Fund reporting in September 2022 that programs had recovered from declines. US malaria efforts include activities primarily through the US President's Malaria Initiative (PMI), overseen by the US Global Malaria Coordinator, and other US activities. For instance, according to Global health policy, US funding for malaria control and research activities was ~US$ 1 billion in FY 2022. The US government's goal under the PMI Strategy 2021-2026 is to work and reduce malaria deaths further and decrease malaria morbidity toward the long-term goal of elimination. Thus, growing DVT cases and technological advancements in DVT preventive pumps are driving the market's growth.

North America Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)

North America Malaria Treatment Market Segmentation

The North America malaria treatment market is segmented based on treatment, drug type, route of administration, distribution channel, end user, and country.

Based on treatment, the North America malaria treatment market is segmented into prescription medications, vaccines, diagnostic tests, and others. The diagnostic tests segment held the largest market share in 2022. The prescription medications segment is categorized into chloroquine phosphate, artemisinin-based combination therapies (ACTs), atovaquone-proguanil, quinine sulfate (qualaquin) with doxycycline, primaquine phosphate, and others.

Based on drug type, the North America malaria treatment market is bifurcated into branded and generic. The generic segment held a larger market share in 2022.

Based on route of administration, the North America malaria treatment market is bifurcated into oral and parenteral & intravenous. The oral segment held a larger market share in 2022.

Based on distribution channel, the North America malaria treatment market is segmented into direct tender, hospital pharmacies, retail pharmacies, online pharmacies, and others. The direct tender segment held the largest market share in 2022.

Based on end user, the North America malaria treatment market is segmented into hospitals, specialty clinics, homecare, and others. The hospitals segment held the largest market share in 2022.

Based on country, the North America malaria treatment market has been categorized into the US, Canada, and Mexico. Our regional analysis states that the US dominated the market in 2022.

AdvaCare Pharma USA LLC, Cipla Ltd, GSK Plc, Lupin Ltd, Novartis AG, Sanofi SA, Sun Pharmaceutical Industries Ltd, Viatris Inc, VLP Therapeutics LLC, and Zydus Healthcare Ltd are among the leading companies operating in the North America malaria treatment market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America malaria treatment market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the North America malaria treatment market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth North America market trends and outlook coupled with the factors driving the malaria treatment market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
Product Code: TIPRE00025040

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 North America Malaria Treatment Market - By Treatment
    • 1.3.2 North America Malaria Treatment Market - By Drug Type
    • 1.3.3 North America Malaria Treatment Market - By Route of Administration
    • 1.3.4 North America Malaria Treatment Market - By Distribution Channel
    • 1.3.5 North America Malaria Treatment Market - By End User
    • 1.3.6 North America Malaria Treatment Market- By Country

2. Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Malaria Treatment Market- Market Landscape

  • 4.1 Overview
  • 4.2 North America PEST Analysis
  • 4.3 Experts Opinion

5. North America Malaria Treatment Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Government and Private Sector's Initiatives to Raise Awareness About Malaria
  • 5.2 Market Restraints
    • 5.2.1 Counterfeit Antimalarial Drugs and Subsequent Drug Resistance
  • 5.3 Market Opportunities
    • 5.3.1 Extending Pipeline of New Drugs and Vaccines
  • 5.4 Future Trends
    • 5.4.1 Rapid Diagnostic Tests
  • 5.5 Impact Analysis

6. Malaria Treatment Market- North America Analysis

  • 6.1 North America Malaria Treatment Market Revenue Forecast and Analysis

7. North America Malaria Treatment Market Analysis - By Treatment

  • 7.1 Overview
  • 7.2 North America Malaria Treatment Market, By Treatment 2021 & 2028 (%)
  • 7.3 Prescription Medications
    • 7.3.1 Overview
    • 7.3.2 Prescription Medication Market Revenue and Forecast to 2028 (US$ Mn)
    • 7.3.3 Chloroquine Phosphate
      • 7.3.3.1 Overview
      • 7.3.3.2 Chloroquine Phosphate Market Revenue and Forecast to 2028 (US$ Mn)
    • 7.3.4 Artemisinin- based Combination Therapies (ACTs)
      • 7.3.4.1 Overview
      • 7.3.4.2 Artemisinin- based Combination Therapies (ACTs) Market Revenue and Forecast to 2028 (US$ Mn)
    • 7.3.5 Atovaquone-Proguanil
      • 7.3.5.1 Overview
      • 7.3.5.2 Atovaquone-Proguanil Market Revenue and Forecast to 2028 (US$ Mn)
    • 7.3.6 Quinine Sulphate (Qualaquin) with Doxycycline
      • 7.3.6.1 Overview
      • 7.3.6.2 Quinine Sulphate (Qualaquin) with Doxycycline Market Revenue and Forecast to 2028 (US$ Mn)
    • 7.3.7 Primaquine Phosphate
      • 7.3.7.1 Overview
      • 7.3.7.2 Primaquine Phosphate Market Revenue and Forecast to 2028 (US$ Mn)
    • 7.3.8 Others
      • 7.3.8.1 Overview
      • 7.3.8.2 Others Market Revenue and Forecast to 2028 (US$ Mn)
  • 7.4 Vaccines
    • 7.4.1 Overview
    • 7.4.2 Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
  • 7.5 Diagnostic Tests
    • 7.5.1 Overview
    • 7.5.2 Diagnostic Tests Market Revenue and Forecast to 2028 (US$ Mn)
  • 7.6 Others
    • 7.6.1 Overview
    • 7.6.2 Others Market Revenue and Forecast to 2028 (US$ Mn)

8. North America Malaria Treatment Market Analysis - By Drug Type

  • 8.1 Overview
  • 8.2 North America Malaria Treatment Market, By Drug Type 2021 & 2028 (%)
  • 8.3 Branded
    • 8.3.1 Overview
    • 8.3.2 Branded Market Revenue and Forecast to 2028 (US$ Mn)
  • 8.4 Generics
    • 8.4.1 Overview
    • 8.4.2 Generics Market Revenue and Forecast to 2028 (US$ Mn)

9. North America Malaria Treatment Market Analysis - By Route of Administration

  • 9.1 Overview
  • 9.2 North America Malaria Treatment Market, By Route of Administration 2021 & 2028 (%)
  • 9.3 Oral
    • 9.3.1 Overview
    • 9.3.2 Oral Market Revenue and Forecast to 2028 (US$ Mn)
  • 9.4 Parenteral and Intravenous Mode
    • 9.4.1 Overview
    • 9.4.2 Parenteral and Intravenous Mode Market Revenue and Forecast to 2028 (US$ Mn)

10. North America Malaria Treatment Market Analysis - By Distribution Channel

  • 10.1 Overview
  • 10.2 North America Malaria Treatment Market, By Distribution Channel 2021 & 2028 (%)
  • 10.3 Direct Tender
    • 10.3.1 Overview
    • 10.3.2 Direct Tender Market Revenue and Forecast to 2028 (US$ Mn)
  • 10.4 Hospital Pharmacies
    • 10.4.1 Overview
    • 10.4.2 Hospital Pharmacies Market Revenue and Forecast to 2028 (US$ Mn)
  • 10.5 Retail Pharmacies
    • 10.5.1 Overview
    • 10.5.2 Retail Pharmacies Market Revenue and Forecast to 2028 (US$ Mn)
  • 10.6 Online Pharmacies
    • 10.6.1 Overview
    • 10.6.2 Online Pharmacies Market Revenue and Forecast to 2028 (US$ Mn)
  • 10.7 Others
    • 10.7.1 Overview
    • 10.7.2 Others Market Revenue and Forecast to 2028 (US$ Mn)

11. North America Malaria Treatment Market Analysis - By End User

  • 11.1 Overview
  • 11.2 North America Malaria Treatment Market, By End User 2021 & 2028 (%)
  • 11.3 Hospitals
    • 11.3.1 Overview
    • 11.3.2 Hospitals Market Revenue and Forecast to 2028 (US$ Mn)
  • 11.4 Specialty Clinics
    • 11.4.1 Overview
    • 11.4.2 Specialty Clinics Market Revenue and Forecast to 2028 (US$ Mn)
  • 11.5 Homecare
    • 11.5.1 Overview
    • 11.5.2 Homecare Market Revenue and Forecast to 2028 (US$ Mn)
  • 11.6 Others
    • 11.6.1 Overview
    • 11.6.2 Others Market Revenue and Forecast to 2028 (US$ Mn)

12. North America Malaria Treatment Market - Country Analysis

  • 12.1 Overview
      • 12.1.1.1 US: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 12.1.1.1.1 US: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 12.1.1.1.2 US: Malaria Treatment Market, by Treatment, 2019-2028 (US$ Million)
        • 12.1.1.1.2.1 US: Malaria Treatment Market, by Prescription Medication, 2019-2028 (US$ Million)
        • 12.1.1.1.3 US: Malaria Treatment Market, by Drug Type, 2019-2028 (US$ Million)
        • 12.1.1.1.4 US: Malaria Treatment Market, by Route of Administration, 2019-2028 (US$ Million)
        • 12.1.1.1.5 US: Malaria Treatment Market, by Distribution Channel, 2019-2028 (US$ Million)
        • 12.1.1.1.6 US: Malaria Treatment Market, by End User, 2019-2028 (US$ Million)
      • 12.1.1.2 Canada: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 12.1.1.2.1 Canada: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 12.1.1.2.2 Canada: Malaria Treatment Market, by Treatment, 2019-2028 (US$ Million)
        • 12.1.1.2.2.1 Canada: Malaria Treatment Market, by Prescription Medication, 2019-2028 (US$ Million)
        • 12.1.1.2.3 Canada: Malaria Treatment Market, by Drug Type, 2019-2028 (US$ Million)
        • 12.1.1.2.4 Canada: Malaria Treatment Market, by Route of Administration, 2019-2028 (US$ Million)
        • 12.1.1.2.5 Canada: Malaria Treatment Market, by Distribution Channel, 2019-2028 (US$ Million)
        • 12.1.1.2.6 Canada: Malaria Treatment Market, by End User, 2019-2028 (US$ Million)
      • 12.1.1.3 Mexico: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 12.1.1.3.1 Mexico: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 12.1.1.3.2 Mexico: Malaria Treatment Market, by Treatment, 2019-2028 (US$ Million)
        • 12.1.1.3.2.1 Mexico: Malaria Treatment Market, by Prescription Medication, 2019-2028 (US$ Million)
        • 12.1.1.3.3 Mexico: Malaria Treatment Market, by Drug Type, 2019-2028 (US$ Million)
        • 12.1.1.3.4 Mexico: Malaria Treatment Market, by Route of Administration, 2019-2028 (US$ Million)
        • 12.1.1.3.5 Mexico: Malaria Treatment Market, by Distribution Channel, 2019-2028 (US$ Million)
        • 12.1.1.3.6 Mexico: Malaria Treatment Market, by End User, 2019-2028 (US$ Million)

13. Industry Landscape

  • 13.1 Overview
  • 13.2 Inorganic Growth Strategies
    • 13.2.1 Overview
  • 13.3 Organic Growth Strategies
    • 13.3.1 Overview

14. Company Profiles

  • 14.1 Zydus Healthcare Ltd
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Sun Pharmaceutical Industries Ltd
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 Sanofi SA
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 GSK Plc
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 Novartis AG
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 Cipla Ltd
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 Viatris Inc
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.8 Lupin Ltd
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments
  • 14.9 AdvaCare Pharma USA LLC
    • 14.9.1 Key Facts
    • 14.9.2 Business Description
    • 14.9.3 Products and Services
    • 14.9.4 Financial Overview
    • 14.9.5 SWOT Analysis
    • 14.9.6 Key Developments
  • 14.10 VLP Therapeutics LLC
    • 14.10.1 Key Facts
    • 14.10.2 Business Description
    • 14.10.3 Products and Services
    • 14.10.4 Financial Overview
    • 14.10.5 SWOT Analysis
    • 14.10.6 Key Developments

15. Appendix

  • 15.1 About The Insight Partners
  • 15.2 Glossary of Terms
Product Code: TIPRE00025040

List Of Tables

  • Table 1. North America Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
  • Table 2. US Malaria Treatment Market, by Treatment - Revenue and Forecast to 2028 (US$ Million)
  • Table 3. US Malaria Treatment Market, by Prescription Medication - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. US Malaria Treatment Market, by Drug Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 5. US Malaria Treatment Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
  • Table 6. US Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. US Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 8. Canada Malaria Treatment Market, by Treatment - Revenue and Forecast to 2028 (US$ Million)
  • Table 9. Canada Malaria Treatment Market, by Prescription Medication - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. Canada Malaria Treatment Market, by Drug Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 11. Canada Malaria Treatment Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
  • Table 12. Canada Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
  • Table 13. Canada Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 14. Mexico Malaria Treatment Market, by Treatment - Revenue and Forecast to 2028 (US$ Million)
  • Table 15. Mexico Malaria Treatment Market, by Prescription Medication - Revenue and Forecast to 2028 (US$ Million)
  • Table 16. Mexico Malaria Treatment Market, by Drug Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 17. Mexico Malaria Treatment Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
  • Table 18. Mexico Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
  • Table 19. Mexico Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 20. Recent Inorganic Growth Strategies
  • Table 21. Recent Organic Growth Strategies in the Malaria Treatment Market
  • Table 22. Glossary of Terms

List Of Figures

  • Figure 1. North America Malaria Treatment Market Segmentation
  • Figure 2. North America Malaria Treatment Market Segmentation, By Country
  • Figure 3. North America Malaria Treatment Market Overview
  • Figure 4. North America Malaria Treatment Market, By Distribution Channel
  • Figure 5. North America Malaria Treatment Market, By Country
  • Figure 6. North America PEST Analysis
  • Figure 7. North America Malaria Treatment Market impact analysis of driver and restraints
  • Figure 8. North America Malaria Treatment Market - Revenue Forecast and Analysis
  • Figure 9. North America Malaria Treatment Market, by Treatment 2021 & 2028 (%)
  • Figure 10. Prescription Medication: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 11. Chloroquine Phosphate: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 12. Artemisinin- based Combination Therapies (ACTs): North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 13. Atovaquone-Proguanil: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 14. Quinine Sulphate (Qualaquin) with Doxycycline: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 15. Primaquine Phosphate: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 16. Others: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 17. Vaccines: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 18. Diagnostic Tests: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 19. Others: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 20. North America Malaria Treatment Market, by Drug Type 2021 & 2028 (%)
  • Figure 21. Branded: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 22. Generics: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 23. North America Malaria Treatment Market, by Route of Administration 2021 & 2028 (%)
  • Figure 24. Oral: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 25. Parenteral and Intravenous Mode: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 26. North America Malaria Treatment Market, by Distribution Channel 2021 & 2028 (%)
  • Figure 27. Direct Tender: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 28. Hospital Pharmacies: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 29. Retail Pharmacies: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 30. Online Pharmacies: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 31. Others: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 32. North America Malaria Treatment Market, by End User 2021 & 2028 (%)
  • Figure 33. Hospitals: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 34. Specialty Clinics: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 35. Homecare: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 36. Others: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 37. North America: Malaria Treatment Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 38. North America: Malaria Treatment Market, by Country, 2021 & 2028 (%)
  • Figure 39. US: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 40. Canada: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 41. Mexico: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!